Glioma-circulating angiogenic cells have a gene expression profile with greater tumor homing capacity (cxcr4, itga6) and more robust proangiogenic potential compared to circulating angiogenic cells from the umbilical cord (developmental neovascularization) and healthy individuals [109]. The gene discussed is ITGA6; the disease is neoplasm.